Your browser doesn't support javascript.
loading
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
Winqvist, Maria; Mozaffari, Fariba; Palma, Marzia; Eketorp Sylvan, Sandra; Hansson, Lotta; Mellstedt, Håkan; Österborg, Anders; Lundin, Jeanette.
Affiliation
  • Winqvist M; Department of Hematology, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden. maria.winqvist@karolinska.se.
  • Mozaffari F; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. maria.winqvist@karolinska.se.
  • Palma M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Eketorp Sylvan S; Department of Hematology, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.
  • Hansson L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Mellstedt H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Österborg A; Department of Hematology, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.
  • Lundin J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Cancer Immunol Immunother ; 66(1): 91-102, 2017 01.
Article in En | MEDLINE | ID: mdl-27815572
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2017 Document type: Article Affiliation country: Sweden Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2017 Document type: Article Affiliation country: Sweden Country of publication: Germany